Use of NSAIDs and COX-2 inhibitors in children with musculoskeletal disorders

被引：6

作者：

Fahey, SM ^{[1
]}

Silver, RM ^{[1
]}

机构：

[1] Med Univ S Carolina, Dept Med, Div Rheumatol & Immunol, Charleston, SC 29425 USA

来源：

JOURNAL OF PEDIATRIC ORTHOPAEDICS | 2003年 / 23卷 / 06期

关键词：

D O I：

10.1097/01241398-200311000-00020

中图分类号：

R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学（修复外科学）];

学科分类号：

摘要：

引用

页码：794 / 799

页数：6

共 50 条

[41] What are the risks of long-term NSAIDs and COX-2 inhibitors?
DeBisschop, M
JOURNAL OF FAMILY PRACTICE, 2003, 52 (03): : 199 - 200
[42] COX-2 inhibitors: lower risk of pancreatitis than other NSAIDs
Reactions Weekly, 2006, 1116 (1) : 4 - 4
[43] Sulfone COX-2 inhibitors increase susceptibility of human LDL and plasma to oxidative modification: comparison to sulfonamide COX-2 inhibitors and NSAIDs
Walter, MF
Jacob, RF
Day, CA
Dahlborg, R
Weng, YJ
Mason, RP
ATHEROSCLEROSIS, 2004, 177 (02) : 235 - 243
[44] Are selective COX-2 inhibitors as effective as NSAIDs in patients with rheumatoid arthritis?
Smucny, J
AMERICAN FAMILY PHYSICIAN, 2004, 69 (03) : 595 - 596
[45] Characterization of users of COX-2 inhibitors and non-specific NSAIDs
Gimeno, V
Castellsague, J
Hopkins, J
Eaton, S
Perez-Gutthann, S
ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 343 - 343
[46] Are COX-2 inhibitors as effective as conventional NSAIDs in acute pain states?
Bannwarth, B
ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (01) : 127 - 127
[47] Cardiovascular and gastrointestinal effects of COX-2 inhibitors and NSAIDs: achieving a balance
Borer, JS
Simon, LS
ARTHRITIS RESEARCH & THERAPY, 2005, 7 (Suppl 4) : S14 - S22
[48] Cardiovascular and gastrointestinal effects of COX-2 inhibitors and NSAIDs: achieving a balance
Jeffrey S Borer
Lee S Simon
Arthritis Research & Therapy, 7
[49] The prospective use of COX-2 inhibitors for the treatment of temporomandibular joint inflammatory disorders
Kerins, CA
Spears, R
Bellinger, LL
Hutchins, B
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2003, 16 (02) : 1 - 9
[50] COX-2, NSAIDs, and cardiovascular risk
McGettigan P.
Henry D.
Current Cardiovascular Risk Reports, 2007, 1 (4) : 296 - 302

← 1 2 3 4 5 →